NCT00117091View on ClinicalTrials.gov

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Anakinra (Kineret®)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00117091 - Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter